Tenderwize
Wróć do wyszukiwania

Medicinal product with active combination Formoterol, Glycopyrroniumbromide and Beclometason (ATC R03AL09)

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Mar 30, 2028 · 585 days left·Open·Supplies
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Arzneimittel mit der Wirkstoffkombination Wirkstoffkombination Formoterol, Glycopyrroniumbromid und Beclometason (ATC-Code: R03AL09)

50/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

20 / 100

Czynniki ryzyka

Contracts may be terminated early if AOK Sachsen-Anhalt decides to tender exclusive contracts for the same active ingre...

The notice explicitly states it is not a public procurement under GWB/EU directives, so legal remedies under procuremen...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Non-exclusive discount agreements for finished medicinal products with active combination Formoterol, Glycopyrroniumbromide and Beclometason (ATC R03AL09)
  • Open-house model: any eligible pharmaceutical company can conclude a contract at any time under uniform conditions
Pokaż pełne podsumowanie

Non-exclusive discount agreement (open-house model) for pharmaceutical products with active combination Formoterol, Glycopyrroniumbromide and Beclometason (ATC R03AL09) by AOK Sachsen-Anhalt. The procedure is explicitly not a public procurement under GWB, published for transparency. Any eligible pharmaceutical company can join at any time under uniform conditions. Contract duration up to 24 months, earliest start 01.06.2026, end 31.05.2028. No estimated value or award criteria provided.

Ryzyka

Contracts may be terminated early if AOK Sachsen-Anhalt decides to tender exclusive contracts for the same active ingre...

The notice explicitly states it is not a public procurement under GWB/EU directives, so legal remedies under procuremen...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Administrative

  • Interested pharmaceutical companies must request participation documents and the contract from the contact address
  • Participation requires fully completed and signed participation documents
  • Submission of documents via postal mail or electronically with qualified electronic signature (eIDAS) to [email protected]

Wymagania mogą być niepełne.

Zamawiający

Lokalizacja

Magdeburg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE258393558

Działalność

Health

Części (1)

LOT-0001

Medicinal product with active combination Formoterol, Glycopyrroniumbromide and Beclometason (ATC R03AL09)

Non-exclusive discount agreement under §130a(8) SGB V for the specified active combination, open-house model with anytime accession. No exclusivity, no individual negotiations. Contract ends 31.05.2028 regardless of start date; may be terminated earlier if exclusive contracts are tendered.

SuppliesEU fundedElectronic submission

Lokalizacja

DEE03, Germany

Czas trwania

2 YEAR

Kategoria

Pharmaceutical products

Termin

Deadline Mar 30, 2028

Szczegóły zamówienia

Data publikacji
20 Apr 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
272002-2026

Dokumenty (1)

Podobne przetargi